US 11472842
Analogues of hepcidin mimetics with improved in vivo half lives
granted A61KA61K38/00A61P
Quick answer
US patent 11472842 (Analogues of hepcidin mimetics with improved in vivo half lives) held by Protagonist Therapeutics, Inc. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61P, A61P3/02